Home | Search | Results place holder

Search Results



place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'Biosimilars: Regulatory Issues'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


Biosimilars: Regulatory Issues
Europe continues to make strides while the US lags behind

 December 2006 £2005 100 %
Global Generics Guide: Part 2
Benchmarking country markets and strategic issue

 June 2006 £8695 43.5 %
When Patients Become Plaintiffs
A Primer on Drug and Medical Device Liability

 January 2006 £1095 33.5 %
World Generic Market Report 2007

 November 2006 £595 33 %
Future of Biosimilars, The
Key opportunities & emerging therapies

 August 2007 £1495 32.55 %
Consolidation in the Generic Pharmaceutical Industry
An evolving landscape

 October 2007 £1250 29.5 %
Biogenerics, The World Market
Biosimilars and Follow-On Biologics at a Crossroads

 April 2008 £2280 27.5 %
Commercial Perspectives: Drug Treatment in End-Stage Renal Disease
The Price of Failure

 January 2006 £4350 22.5 %
Biosimilars
Evolution or Revolution

 September 2006 £1950 22.4 %
A Guide to Biosimilars, Biogenerics and Follow-on Biologics

 January 2007 £1095 19.95 %
Biosimilars: a viable market?

 September 2008 £1295 17.85 %
Teva Pharmaceutical Industries Generics Company Intelligence Report

 June 2008 £195 17 %
Pipeline/Commercial Insight: Supportive Care in Oncology
Significant growth opportunities exist in new supportive care indications

 June 2007 £7600 16.5 %
Drug Approval Trends at the FDA and EMEA
Process Improvements, Heightened Scrutiny and Industry Response

 April 2008 £1995 15.75 %
Generic Series: An Introduction to the Canadian Generics Market
Key trends and leading companies shaping the market

 June 2007 £2005 13.65 %
Biogenerics: Challenges and Promise
Challenges and Promise

 January 2005 £650 12.95 %
Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making

 May 2007 £1695 11.55 %
Pharmaceutical Regulatory Affairs in The Eu & US

 January 2006 £1095 11.2 %
New Dynamics and Challenges in The Generics Market 2007

 January 2007 £1870 11.2 %
Pharmaceutical Regulatory Affairs in the EU and US

 December 2006 £1095 9.1 %
The Pharmaceutical Industry 2008
Current and Future Trends and Strategic Issues Shaping Pharma

 March 2008 £3010 8.75 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 8.05 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 8.05 %
Global Clinical Trial Business Report & Analysis 2008-2018

 July 2008 £1499 7.7 %
Commercial Insight Top 20 Cancer Therapeutics

 July 2006 £8695 7 %
Commercial Insight: Cardiovascular market overview
Raft of patent expires threaten blockbusters

 October 2007 £7600 6.65 %
Biomanufacturing Strategies
Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management

 September 2007 £1495 6.3 %
Forecast Insight: Multiple Sclerosis
Tysabri to prevail despite safety setbacks

 August 2008 £7600 6.3 %
World Generics Market 2006-2011; The

 May 2006 £1499 5.95 %
place holder